In the first quarter of FY2027 ending March 2027, revenue reached 14,159 million Yen (up 9.0% YoY), but operating profit was only 32 million Yen (down 95.7%), resulting in a net loss. Segments such as Medical Institutions and Hospice achieved revenue growth, but profit pressures remain, indicating a continued challenging earnings environment. Total assets expanded to 101,144 million Yen, with liabilities increasing due to higher borrowings. There are no changes to the earnings outlook, and the company continues to promote efficiency and growth strategies.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"9158","jir_company_name":"C.U.S. Corporation","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-07-30","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/07\/9158-20260730-01.pdf","jir_short_summary":"In the first quarter of FY2027 ending March 2027, revenue reached 14,159 million Yen (up 9.0% YoY), but operating profit was only 32 million Yen (down 95.7%), resulting in a net loss. Segments such as Medical Institutions and Hospice achieved revenue growth, but profit pressures remain, indicating a continued challenging earnings environment. Total assets expanded to 101,144 million Yen, with liabilities increasing due to higher borrowings. There are no changes to the earnings outlook, and the company continues to promote efficiency and growth strategies.","jir_summary":"### Performance Overview\nThe Group achieved revenue of 14,159 million Yen (up 9.0% YoY) in the first quarter of FY2027 ending March 2027, but reported an operating loss of 32 million Yen (down 95.7%), and a net loss of 281 million Yen attributable to the owners of the parent company. Segment-wise, revenue increased in Medical Institutions and Hospice, but profit pressures persisted, leading to an overall challenging earnings environment. Total assets grew to 101,144 million Yen, with liabilities increasing due to higher borrowings. The outlook remains unchanged, and the company continues to focus on streamlining operations and growth strategies.\n\n### Future Outlook and Impact on Shareholders\nThe company maintains its full-year FY2027 earnings forecast, expecting revenue of 64,600 million Yen (up 18.9% YoY) and net income of 1,100 million Yen (down 59.9%). Despite ongoing profit pressures, the company is exploring growth opportunities through new businesses and overseas expansion. Dividend payments are expected to remain stable, with no plans announced for share buybacks or capital policy modifications. The company will continue implementing measures to ensure business stability and growth.","jir_financial_highlights":"Revenue: 14,159 million Yen (Up 9.0% YoY)\nOperating Income: 32 million Yen (Down 95.7% YoY)\nNet Income Attributable to Owners of Parent: -281 million Yen (Turned from 208 million Yen profit in the same period last year)","jir_category":"","jir_hashtags":"#C.U.S., #FinancialResults, #JapaneseStocks","jir_key_figures":"Revenue: 14,159 million Yen (+9.0% YoY)\nNet Income Attributable to Owners of Parent: -281 million Yen (last year 208 million Yen)\nTotal Assets: 101,144 million Yen (increase of 3,196 million Yen from the previous period)","jir_meta_title":"[C.U.S.] Q1 2027 Financial Results | Revenue Growth but Net Loss Widens","jir_meta_description":"Overview of C.U.S.'s Q1 FY2027 financial results. Revenue of 14,159 million Yen (+9.0%) but expanding net loss, including future prospects.","jir_og_title":"[C.U.S.] Q1 2027 Financial Results | Revenue Growth but Net Loss Widens","jir_og_description":"Analysis of C.U.S.'s latest financial results. Revenue increased, but net loss widened, with details on future strategies and performance outlook.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":57503,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-90611","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n